Biblio

Export 496 results:
Author Title Type Year
Filters: First Letter Of Keyword is N  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Neovascularization, Pathologic
R. Harris, Miners, J. Scott, Allen, S., and Love, S., VEGFR1 and VEGFR2 in Alzheimer's Disease., J Alzheimers Dis, vol. 61, no. 2, pp. 741-752, 2018.
Nerve Degeneration
A. de Calignon, Polydoro, M., Suárez-Calvet, M., William, C., Adamowicz, D. H., Kopeikina, K. J., Pitstick, R., Sahara, N., Ashe, K. H., Carlson, G. A., Spires-Jones, T. L., and Hyman, B. T., Propagation of tau pathology in a model of early Alzheimer's disease., Neuron, vol. 73, no. 4, pp. 685-97, 2012.
D. A. Gimbel, Nygaard, H. B., Coffey, E. E., Gunther, E. C., Laurén, J., Gimbel, Z. A., and Strittmatter, S. M., Memory impairment in transgenic Alzheimer mice requires cellular prion protein., J Neurosci, vol. 30, no. 18, pp. 6367-74, 2010.
C. Deochand, Tong, M., Agarwal, A. R., Cadenas, E., and de la Monte, S. M., Tobacco Smoke Exposure Impairs Brain Insulin/IGF Signaling: Potential Co-Factor Role in Neurodegeneration., J Alzheimers Dis, vol. 50, no. 2, pp. 373-86, 2016.
R. Weissmann, Hüttenrauch, M., Kacprowski, T., Bouter, Y., Pradier, L., Bayer, T. A., Kuss, A. W., and Wirths, O., Gene Expression Profiling in the APP/PS1KI Mouse Model of Familial Alzheimer's Disease., J Alzheimers Dis, vol. 50, no. 2, pp. 397-409, 2016.
R. Yu, Deochand, C., Krotow, A., Leão, R., Tong, M., Agarwal, A. R., Cadenas, E., and de la Monte, S. M., Tobacco Smoke-Induced Brain White Matter Myelin Dysfunction: Potential Co-Factor Role of Smoking in Neurodegeneration., J Alzheimers Dis, vol. 50, no. 1, pp. 133-48, 2016.
H. - F. Wang, Wan, Y., Hao, X. - K., Cao, L., Zhu, X. - C., Jiang, T., Tan, M. - S., Tan, L., Zhang, D. - Q., Tan, L., and Yu, J. - T., Bridging Integrator 1 (BIN1) Genotypes Mediate Alzheimer's Disease Risk by Altering Neuronal Degeneration., J Alzheimers Dis, vol. 52, no. 1, pp. 179-90, 2016.
Nerve Net
D. Kapogiannis and Mattson, M. P., Disrupted energy metabolism and neuronal circuit dysfunction in cognitive impairment and Alzheimer's disease., Lancet Neurol, vol. 10, no. 2, pp. 187-98, 2011.
J. Zhou, Gennatas, E. D., Kramer, J. H., Miller, B. L., and Seeley, W. W., Predicting regional neurodegeneration from the healthy brain functional connectome., Neuron, vol. 73, no. 6, pp. 1216-27, 2012.
T. Zhang, Li, H., Zhang, J., Li, X., Qi, D., Wang, N., and Zhang, Z., Impacts of High Serum Total Cholesterol Level on Brain Functional Connectivity in Non-Demented Elderly., J Alzheimers Dis, vol. 50, no. 2, pp. 455-63, 2016.
L. Pasquini, Scherr, M., Tahmasian, M., Myers, N. E., Ortner, M., Kurz, A., Förstl, H., Zimmer, C., Grimmer, T., Akhrif, A., Wohlschläger, A. M., Riedl, V., and Sorg, C., Increased Intrinsic Activity of Medial-Temporal Lobe Subregions is Associated with Decreased Cortical Thickness of Medial-Parietal Areas in Patients with Alzheimer's Disease Dementia., J Alzheimers Dis, vol. 51, no. 1, pp. 313-26, 2016.
S. Toniolo, Di Lorenzo, F., Scarioni, M., Frederiksen, K. Steen, and Nobili, F., Is the Frontal Lobe the Primary Target of SARS-CoV-2?, J Alzheimers Dis, vol. 81, no. 1, pp. 75-81, 2021.
J. R. Petrella, Michael, A. M., Qian, M., Nwosu, A., Sneed, J., Goldberg, T. E., Devanand, D. P., and P Doraiswamy, M., Impact of Computerized Cognitive Training on Default Mode Network Connectivity in Subjects at Risk for Alzheimer's Disease: A 78-week Randomized Controlled Trial., J Alzheimers Dis, vol. 91, no. 1, pp. 483-494, 2023.

Pages